From The

Expert perspectives focused on the latest bioanalytical topic & trends

Update on CAR T-Cell Therapies for the Treatment of Cancer

Chimeric Antigen Receptor (CAR) therapies are a type of cell therapy that consists of modifying immune cells to attack various forms of cancerous cells. While this is a relatively new therapeutic class, there are already a number of versions that are being developed or already approved for treatment.   Let’s start with the source of the cells being modified. In general, there are two categories of CAR immune cells: Autologous and

Read More »

Speak To A Scientist

    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.